本文へ移動
cccskills
無料GitHub で公開

es-cgm-vs-none-t2d-insu-su-high-risk

This skill suggests using real-time continuous glucose monitoring (CGM) rather than no CGM for outpatients with type 2 diabetes (T2D) who take insulin and/or sulfonylureas and are at high risk for hypoglycemia. It is triggered by clinician questions such as "Should I use CGM for this T2D patient on insulin or sulfonylureas with high hypoglycemia risk?" or "Is CGM indicated for this patient?"

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.8 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

CGM vs No CGM for T2D on Insulin/SU at High Risk

STEP 1 — Gather Information

Collect patient demographics, confirm type 2 diabetes outpatient status, list current medications (focus on insulin and/or sulfonylureas), and document hypoglycemia history (severe episodes requiring assistance, impaired awareness of hypoglycemia, renal/hepatic dysfunction, age-related risk).

STEP 2 — Rule In / Rule Out

Determine if the patient is an outpatient with T2D prescribed insulin and/or a sulfonylurea. If yes, proceed to assess hypoglycemia risk; if no, CGM is not indicated per this recommendation (stop).

STEP 3 — Classify or Stratify

Assess for high hypoglycemia risk: history of severe hypoglycemia requiring assistance, impaired awareness of hypoglycemia (IAH), or medical conditions predisposing to severe hypoglycemia (renal/hepatic dysfunction, older age). If high risk, proceed; if not high risk, CGM is not suggested per this guideline (though consider other indications).

STEP 4 — Decide

For patients meeting criteria (T2D outpatient on insulin/SU and high hypoglycemia risk), suggest initiating real-time CGM rather than no CGM, combined with periodic point-of-care blood glucose (POC-BG) testing to validate CGM accuracy.

Clinical Guardrails / Mimics / Pitfalls

CGM does not replace SMBG; fingerstick glucose remains necessary for calibration, confirmation of discordant symptoms, and sensor warm-up periods. Ensure patient receives education on device use, troubleshooting, interpreting trend arrows, and responding to alerts. Be mindful of cost, insurance coverage, and patient acceptability; avoid using CGM alone for acute treatment decisions without confirmatory SMBG. Note that inpatient CGM use lacks FDA approval but may be used under enforcement discretion; assess patient ability to handle device alerts and data burden.

Concrete Clinical Example

A 68‑year‑old man with T2D on basal insulin glargine and glimepiride (a sulfonylurea) reports recurrent hypoglycemia unawareness and two severe hypoglycemic events requiring assistance in the past month. He is an outpatient on insulin/SU and at high risk. The skill suggests initiating real‑time CGM with diabetes education and periodic SMBG validation.

Source: Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する